RETRACTED: Glypican 1 Stimulates S Phase Entry and DNA Replication in Human Glioma Cells and Normal Astrocytes
Authors:
Open Access
- 1 November 2013
- journal article
- retracted article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 33 (22) , 4408-4421
Abstract
Malignant gliomas are highly lethal neoplasms with limited treatment options. We previously found that the heparan sulfate proteoglycan glypican 1 (GPC1) is universally and highly expressed in human gliomas. In this study, we investigated the biological activity of GPC1 expression in both human glioma cells and normal astrocytes in vitro. Expression of GPC1 inactivates the G1/S checkpoint and strongly stimulates DNA replication. Constitutive expression of GPC1 causes DNA rereplication and DNA damage, suggesting a mutagenic activity for GPC1. GPC1 expression leads to a significant downregulation of the tumor suppressors pRb, Cip/Kip cyclin-dependent kinase inhibitors (CKIs), and CDH1, and upregulation of the pro-oncogenic proteins cyclin E, cyclin-dependent kinase 2 (CDK2), Skp2, and Cdt1. These GPC1-induced changes are accompanied by a significant reduction in all types of D cyclins, which is independent of serum supplementation. It is likely that GPC1 stimulates the so-called Skp2 autoinduction loop, independent of cyclin D-CDK4/6. Knockdown of Skp2, CDK2, or cyclin E, three key elements within the network modulated by GPC1, results in a reduction of the S phase and aneuploid fractions, implying a functional role for these regulators in GPC1-induced S phase entry and DNA rereplication. In addition, a significant activation of both the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathways by GPC1 is seen in normal human astrocytes even in the presence of growth factor supplement. Both pathways are constitutively activated in human gliomas. The surprising magnitude and the mitogenic and mutagenic nature of the effect exerted by GPC1 on the cell cycle imply that GPC1 may play an important role in both glioma tumorigenesis and growth.Keywords
This publication has 45 references indexed in Scilit:
- Control over DNA replication in time and spaceFEBS Letters, 2012
- Glypican-1 Stimulates Skp2 Autoinduction Loop and G1/S Transition in Endothelial CellsJournal of Biological Chemistry, 2012
- Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitorsTrends in Cell Biology, 2012
- Prevention of DNA re-replication in eukaryotic cellsJournal of Molecular Cell Biology, 2011
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Genomic stability and tumour suppression by the APC/C cofactor Cdh1Nature Cell Biology, 2008
- A Skp2 autoinduction loop and restriction point controlJournal of Cell Biology, 2007
- Deregulated Replication Licensing Causes DNA Fragmentation Consistent with Head-to-Tail Fork CollisionMolecular Cell, 2006
- Distinct Mechanisms for Regulating the Tumor Suppressor and Antiapoptotic Functions of RbJournal of Biological Chemistry, 2003